This guest blog was contributed by Caroline Lee from the Cambridge Institute of Public Health, University of Cambridge.
The most debilitating symptoms of dementia affect a person’s ability to carry out daily activities, yet are also some of the most difficult to treat with medication.
As the health and social care burden of dementia increases, so does interest in alternatives to medication. However, the widespread take up of alternative treatments must be grounded in robust analysis both of health outcomes and of cost-effectiveness.
An off the shelf product claiming to improve memory in early Alzheimer’s disease seems to offer both hope and convenience. However, some of these, including Souvenaid, are governed by the food rather than the drugs industry and, as such, regulated differently.
While these new ‘non-pharmacological products’ are already on the market, potential new drugs remain in clinical trial, and the scientific community continues to strive for new knowledge based on robust evidence of ‘what works’. Continue reading “Guest blog – What alternative treatments work for people with dementia?”